Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
5.10
+0.03 (0.59%)
Dec 22, 2025, 10:25 AM EST - Market open
Alpha Tau Medical Employees
Alpha Tau Medical had 125 employees as of December 31, 2024. The number of employees increased by 4 or 3.31% compared to the previous year.
Employees
125
Change (1Y)
4
Growth (1Y)
3.31%
Revenue / Employee
n/a
Profits / Employee
-$319,736
Market Cap
434.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 125 | 4 | 3.31% |
| Dec 31, 2023 | 121 | 27 | 28.72% |
| Dec 31, 2022 | 94 | 11 | 13.25% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DRTS News
- 13 days ago - Alpha Tau Successfully Treats First Patient in its U.S. Trial for Patients with Recurrent Glioblastoma at the James Cancer Hospital at The Ohio State University - GlobeNewsWire
- 4 weeks ago - Alpha Tau Announces Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Alpha Tau to Participate at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 2 months ago - Alpha Tau Announces Receipt of Radioactive Material License for its New Hampshire Manufacturing Facility, Advancing Towards Commercial Readiness - GlobeNewsWire
- 2 months ago - Altamirano PLLC Issues Notice to Inspired Healthcare Capital (IHC) Investors on Recovery Options - GlobeNewsWire
- 2 months ago - Alpha Tau Medical: Localized Alpha Radiation, A New Paradigm In Oncology - Seeking Alpha
- 3 months ago - Alpha Tau Successfully Treats First Patient in its U.S. Multi-Center Pancreatic Cancer Clinical Trial - GlobeNewsWire
- 4 months ago - Alpha Tau to Participate in Five September Investor Conferences - GlobeNewsWire